We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+13.91%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$1.75B
AUM Growth
+$245M
Cap. Flow
+$59.6M
Cap. Flow %
3.41%
Top 10 Hldgs %
53.3%
Holding
1,208
New
104
Increased
199
Reduced
182
Closed
53

Top Buys

Rank Stock Value
1
DAVA icon
Endava
DAVA
+$18.6M
2
V icon
Visa
V
+$9.51M
3
MSFT icon
Microsoft
MSFT
+$8.87M
4
NKE icon
Nike
NKE
+$8.01M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$7.42M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$21.7M
2
AAPL icon
Apple
AAPL
+$5.25M
3
CYBR
CyberArk
CYBR
+$4.29M
4
MA icon
Mastercard
MA
+$3.8M
5
AMZN icon
Amazon
AMZN
+$3.18M

Sector Composition

Rank Sector Weight
1 Technology 26.55%
2 Financials 22.14%
3 Consumer Discretionary 17.13%
4 Communication Services 11.45%
5 Healthcare 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUGT icon
1126
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.4B
$278 ﹤0.01%
4
KZIA
1127
Kazia Therapeutics
KZIA
$155M
$276 ﹤0.01%
1
MERC icon
1128
Mercer International
MERC
$25.9M
$267 ﹤0.01%
26
OVV icon
1129
Ovintiv
OVV
$17.9B
$258 ﹤0.01%
+18
New +$211
CRIS icon
1130
Curis
CRIS
$3.61M
0
XBIO icon
1131
Xenetic Biosciences
XBIO
$9.33M
$216 ﹤0.01%
11
UVXY icon
1132
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$276M
0
HYMCZ
1133
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
$97 ﹤0.01%
268
GALT icon
1134
Galectin Therapeutics
GALT
$405M
$90 ﹤0.01%
40
FRO icon
1135
Frontline
FRO
$9.84B
$87 ﹤0.01%
14
SCPX
1136
DELISTED
Scorpius Holdings, Inc.
SCPX
0
GENE
1137
DELISTED
Genetic Technologies Ltd.
GENE
$72 ﹤0.01%
4
AIG.WS
1138
DELISTED
American International Group, Inc.
AIG.WS
$64 ﹤0.01%
531
SCKT icon
1139
Socket Mobile
SCKT
$5.48M
$62 ﹤0.01%
+26
New +$59
ELOX
1140
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
0
BNBX
1141
DELISTED
BNB PLUS CORP
BNBX
0
BLRX
1142
BioLineRX
BLRX
$11.4M
0
NNVC icon
1143
NanoViricides
NNVC
$31.7M
$23 ﹤0.01%
8
BNTC icon
1144
Benitec Biopharma
BNTC
$428M
0
LSTA icon
1145
Lisata Therapeutics
LSTA
$15.2M
$14 ﹤0.01%
1
TPST icon
1146
Tempest Therapeutics
TPST
$17.5M
0
GTE icon
1147
Gran Tierra Energy
GTE
$349M
$11 ﹤0.01%
3
GRCE
1148
Grace Therapeutics
GRCE
$44.6M
$10 ﹤0.01%
1
OIBR.C
1149
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$8 ﹤0.01%
4
FAZ
1150
Direxion Daily Financial Bear 3x ETF
FAZ
$88.2M
0

Similar funds

RBC Europe's Q4 2020 Portfolio in Review

As of Q4 2020, RBC Europe held 1,208 positions worth $1.75B, up 16% from $1.5B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

RBC Europe deployed $59.6M of net new capital in Q4 2020, opening 104 new positions and adding to 199 existing holdings. Its largest new stake was Endava: 275,000 shares worth $21.1M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $21.7M trimmed.

  • RBC Europe's largest Q4 2020 buy was Endava: 275,000 shares worth $21.1M.
  • RBC Europe added most to Visa in Q4 2020, an estimated $9.51M increase.
  • RBC Europe's biggest Q4 2020 reduction was Tesla, cutting an estimated $21.7M.
  • RBC Europe fully exited Domino's in Q4 2020, selling an estimated $329K.
  • RBC Europe's ten largest holdings make up 53% of its $1.75B portfolio in Q4 2020.
  • RBC Europe opened 104 new positions and closed 53 in Q4 2020.
  • RBC Europe's portfolio value rose 16% quarter-over-quarter to $1.75B.

Based on RBC Europe's 13F filing for Q4 2020, filed 9 Nov 2023.